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Key Points 
 
 DNA methylation is a potential mechanism for propagating the effects of 
environmental risk exposures on child and adolescent mental health; 
  
 There is recent growth in publications assessing DNA methylation from 
peripheral samples (blood, buccal cells) in children and adolescents; 
 
 Very few published studies exist that can test key mediational DNAm 
hypotheses – ones that measure risk exposures, DNAm, and psychopathology 
in the context of a prospective longitudinal design; 
 
 We provide a strategic review of existing studies on living children – with 
risk exposure and/or psychopathology measured in childhood or adolescence  
 
 We highlight current challenges that, if overcome, can help assess DNA 
methylation as a causal mechanism, or biomarker, in the link between 
environmental risk exposure and child and adolescent psychopathology 
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Abstract 
Background: DNA methylation (DNAm) is a potential mechanism for propagating the 
effects of environmental exposures on child and adolescent mental health. In recent years, 
this field has experienced steady growth. Methods: We provide a strategic review of the 
current child and adolescent literature in order to evaluate evidence for a mediating role of 
DNAm in the link between environmental risks and psychopathological outcomes, with a 
focus on internalising and externalising difficulties. Results:  Based on the studies presented, 
we conclude that there is preliminary evidence to support that (i) environmental factors, such 
as diet, neurotoxic exposures and stress, influence offspring DNAm, and that (ii) variability 
in DNAm, in turn, is associated with child and adolescent psychopathology. Overall, very 
few studies have examined DNAm in relation to both exposures and outcomes, and almost all 
analyses have been correlational in nature. Conclusions: DNAm holds potential as a 
biomarker indexing both environmental risk exposure and vulnerability for child 
psychopathology. However, the extent to which it may represent a causal mediator is not 
clear. In future, collection of prospective risk exposure, DNAm and outcomes – as well as 
functional characterization of epigenetic findings – will assist in determining the role of 
DNAm in the link between risk exposure and psychopathology.  
Keywords: DNA methylation; Epigenetics; Developmental Psychopathology; Childhood; 
Adolescence; Environmental risk; Internalising problems; Externalising problems 
Abbreviations: 5hmC, 5-hydroxymethylcytosine; ADHD, attention deficit hyperactivity 
disorder; CP, conduct problems; CpG, cytosine-guanine pair; CU, callous-unemotional; 
DNAm, DNA methylation; EWAS, epigenome-wide association studies; HPA, 
hypothalamic–pituitary axis; mQTL, methylation quantitative trait locus; MR, Mendelian 
randomization; ODD, oppositional defiant disorder; WGBS, whole-genome bisulfite 
sequencing.  
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Introduction 
Data indicate the importance of early adversity in the development of child and adolescent 
psychopathology (Barker & Maughan, 2009; O'Connor, Heron, Golding, Beveridge, & 
Glover, 2002). Indeed, both prenatal (e.g. maternal stress, psychopathology) and postnatal 
(e.g. childhood maltreatment) adversities have been found to increase risk for a wide range of 
negative mental health outcomes, including internalising and externalising difficulties. 
Importantly, the effects of early adversity can persist well into the adult years, long after the 
exposure itself has ceased (e.g. Yehuda, McFarlane, & Shalev, 1998). Yet, the exact 
mechanisms mediating this enduring vulnerability remain unclear. Consequently, a key 
challenge for research is to understand how adverse experiences impact biological 
development (and function) in a manner that engenders long-term risk for psychopathology.  
 In recent years DNA methylation (DNAm) – an epigenetic process that regulates 
gene expression – has emerged as a potential mechanism through which the genome can 
‘capture’ the effects of environmental exposures and propagate their influence (McKay et al., 
2012). DNAm refers to the addition of a methyl group, primarily in the context of cytosine-
guanine (CpG) dinucleotides (Jaenisch & Bird, 2003). In the human genome, CpG sites often 
cluster in CpG-islands, which themselves tend to be embedded in promoter regions of genes. 
Methylated CpG islands impede transcription factors from accessing the DNA sequence. 
Increased methylation in these regions is typically associated with inhibition of gene 
transcription (i.e. gene silencing) and chromatin compaction, and hence can provide a 
mechanism by which the DNAm can trigger long-term alterations in phenotypes. Of note, 
DNAm is also influenced by genetic factors (McRae et al., 2014). Indeed, twin research has 
shown that DNAm is highly heritable near the promoter regions of genes (Kaminsky et al., 
2009) and molecular studies report that genetic influence on DNAm levels in peripheral 
samples (blood) can identified as early infancy (cord samples at birth; Teh et al., 2014) and 
across the life course (Gaunt et al., 2016). The interest in DNAm within the field of 
developmental psychology stems from studies that suggest DNAm can be both sensitive to a 
range of environmental exposures across the lifespan (Kofink, Boks, Timmers, & Kas, 2013) 
and – at the same time – associate with altered biological processes underlying the emergence 
of disease states (Szyf, 2015). Of note,  
Over the past decade, a growing number of studies have tested whether DNAm is 
associated with environmental risks or with different forms of psychopathology. As shown in 
Figure 1, DNAm studies have been steadily rising since 2010, with many more studies 
relating DNAm to risk exposures compared to psychopathological outcomes. Of these 
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published studies, the majority have focused on adult populations, with a much smaller 
number focusing on childhood. In fact, the least common studies are those that would make it 
possible to test key mediational DNAm hypotheses – ones that measure risk exposures, 
DNAm, and psychopathology in the context of a prospective longitudinal design. Thus, while 
the field is growing fast, there is still a relative dearth of studies featuring the necessary data 
to test DNAm as a mediator in the link between prior environmental risk exposure(s) and 
subsequent psychopathological outcomes during childhood and adolescence. 
Delineating the mechanistic role of DNAm is crucial in order to clarify its potential 
utility in the prevention, detection, and treatment of psychopathology. The ‘promise’ of a 
meditational framework is that – if DNAm is identified as a causal link in the etiology of a 
disease – then reversing epigenetic marks (e.g. through multimodal interventions including 
epigenetic therapy; Szyf, 2015) might help alleviate the burdens of disease. It is also equally 
possible, however, that DNAm functions as a non-causal biomarker of environmental risk 
exposure and/or stress-related disorders. Here, differences in DNAm may be a consequence 
of disease etiology (e.g. risk exposure and/or psychopathology) rather than a causal 
mechanism within the disease process. In aetiologic epidemiology, this is termed “reverse 
causality” (Richmond, Al-Amin, Smith, & Relton, 2014). Yet even in this situation DNAm 
can still serve as an important biomarker of disease and have clinical utility. For example, 
epigenetic patterns have already been shown to be useful in cancer detection, prognosis and 
even predicting response to treatment (Ladd-Acosta & Fallin, 2015).  
  In this review, we discuss DNAm as a potential mechanism linking environmental 
risk exposure and the development of child and adolescent psychopathology. Figure 2 (panel 
A) contains the conceptual mediation model that guides this strategic review. Specifically, we 
provide an overview of studies (published by 15-Oct-2016) that have examined DNAm based 
on peripheral tissues (e.g. blood, saliva/buccal cells) in living children, with risk exposure 
and/or psychopathology measured in childhood or adolescence. This is therefore a strategic 
(non-systematic) review of the literature. First, we begin with a brief introduction to 
epigenetics in general, and DNAm in particular. Second, we review studies that have 
examined the a path of our proposed mediation model (i.e. exposure  DNAm). We include 
environmental risks that have been previously associated with child and adolescent 
psychopathology, including dietary, neurotoxic and stress exposures. Third, we describe 
studies that have examined the b path of the model (i.e. DNAm  psychopathology), 
focusing on internalising and externalising problems. We then highlight the small number of 
integrative studies that have examined DNAm as a mediator in the link between risk exposure 
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and psychopathology (i.e. the a*b path). Finally, we close with a discussion of current 
challenges and propose five key ways to move the field forward in future.    
 
Overview of the epigenome 
Epigenetic mechanisms influence dynamic changes in transcription independent of the 
genomic DNA sequence, primarily via modifications to DNA, histone proteins, and 
chromatin structure (Jaenisch & Bird, 2003). Epigenetic processes are essential for normal 
cellular development and differentiation, and allow the long-term regulation of gene function 
through non-mutagenic mechanisms (Henikoff & Matzke, 1997). The term epigenetics was 
first introduced by Waddington, who tried to understand how cells differentiate into diverse 
tissue types, despite containing the same genome (Waddington, 1957). Nowadays, it is clear 
that epigenetic modifications are not only fundamental for the establishment and maintenance 
of cellular identity, but also co-ordinate a much wider range of biological processes, 
including genomic imprinting and X chromosome inactivation, as well as stress-response, 
immune function and neurodevelopment. Importantly, because epigenetic processes have 
been shown to respond to both genetic and environmental factors, they represent a potential 
mechanism that can help explain the biology of gene-environmental interplay and disease 
susceptibility across the lifespan (Meaney, 2010).  
One of the most extensively researched epigenetic mechanisms is DNAm, which – as 
stated earlier – refers to the addition of a methyl group, primarily in the context of cytosine-
guanine (CpG). This process affects about 4 % of CpG pairs, which in turn impacts the 
binding potential of transcription factors. Many (but not all) genes demonstrate an inverse 
correlation between the degree of methylation and the level of expression. While 5-
methylcytosine (5mC) is the most common form of DNAm, particularly in peripheral tissues 
(blood, buccal cells), other DNAm processes have recently been discovered, such as 5-
hydroxymethylcytosine (5hmC). As this review is focused on 5mC DNAm, we refer the 
reader to a high quality review that covers 5hmC as well as a range of other epigenetic 
mechanisms (Syzf, 2015). 
DNAm can be studied through a variety of different approaches.  Global DNAm is 
used as proxy for the overall degree of methylation in the genome and can be derived using 
methods such as high performance liquid chromatography or mass spectrophotometry. 
Candidate gene approaches focus on preselected genes based on a priori hypotheses (e.g. via 
pyrosequencing and related PCR or sequencing applications). Despite their utility, candidate 
gene approaches may offer a limited insight into the pathophysiology of complex diseases, 
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which are likely to reflect the influence of multiple genes of potentially unknown function. In 
contrast, the use of epigenome-wide, hypothesis-free approaches can enable the identification 
of epigenetic marks in previously unconsidered biological systems. Methods to assess DNAm 
across the genome include whole-genome bisulfite sequencing (WGBS) or array, bead-type 
hybridization. While WGBS has in-depth coverage of millions of CpGs, costs can be high. 
As an alternative, bead-type hybridization has become very popular, particularly the use of 
the Illumina microarrays. Of these, the most often-used platform has been the Illumina 450k 
array, which interrogates >450,000 CpGs across the genome. Although the array is human-
specific, making cross-species comparisons unfeasible, it has become an array-of-choice to 
many researchers interested in studying the associations between DNAm and 
psychopathological traits or their risk factors. However, overall coverage of CpG sites is still 
low (only around 2% of all sites in the human genome) with some features such as enhancer 
regions being severely underrepresented. Also, as the platform was originally designed to 
study cancer, findings may be somewhat biased toward annotated genes related to 
oncological function, omitting probes that are currently unannotated or might be more 
relevant in other processes such as epigenetic inheritance or imprinting. In terms of technical 
artefacts, batch effects and the presence of cross-reactive probes can be a significant source 
of noise. The introduction of the newer Illumina EPIC BeadChip shows promise in 
addressing this bias by measuring DNAm at over 850,000 CpG sites, with increased genomic 
coverage, high reproducibility and reliability (Pidsley et al., 2016). However, increased 
coverage also implies statistical difficulties related to multiple testing and false positives. For 
a more in-depth discussion on these methods and arrays, see Non and Thayer (2015). 
  Much of what is known about DNAm has come from experimental animal models, 
which enable the manipulation of environmental exposures, the investigation of time- and 
tissue-specific effects on DNAm, and the characterization of downstream consequences on 
gene expression and behaviour. For example, ground-breaking rodent studies by Weaver et 
al. (2004) showed for the first time that differences in the social environment, such as 
maternal licking and grooming behaviour, could cause long-term epigenetic alterations of the 
glucocorticoid receptor (NR3C1) gene within the hippocampus of offspring, in turn driving 
inter-individual differences in stress response. Deriving similar evidence in human 
populations has been difficult, as experimental manipulation and access to relevant tissues is 
often unfeasible. Post-mortem brain tissues represent one important tool for testing the 
translational potential of animal findings to humans. For example, Weaver et al.’s NR3C1 
findings have been replicated in humans, based on hippocampal tissue from suicide 
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completers retrospectively identified as abused during childhood (e.g. McGowan et al., 
2009). Among the drawbacks of post-mortem studies, however, is that factors such as pH, 
postmortem interval, and preservation methods might have confounding effects on DNA 
methylation and that these studies are usually retrospective, precluding the possibility of 
testing mediational hypotheses. In living humans, studies have to rely on DNAm from 
peripheral tissues (e.g. blood, saliva). Because DNAm patterns can differ across tissues, the 
extent to which we may infer epigenetic patterns in the living brain (likely the most relevant 
organ for the study of psychopathology) based on peripheral samples is still unclear, although 
there is evidence that a subset of peripheral DNAm markers may proxy methylation status of 
brain tissue (Walton et al., 2015). 
 
Environmental risk exposure and DNAm: the a path 
In this section, we review evidence for an association between environmental effects on 
DNAm, spanning gestation through to childhood. We focus on risks that have been 
previously associated with child internalising and externalising problems, including dietary, 
neurotoxic and stress exposures. 
Nutrition.  Pre- and postnatal nutrition is critical for healthy neurological 
development. DNAm is also highly responsive to diet as nutrients and bioactive compounds 
can alter the expression of genes at the transcriptional level and result in long-term 
phenotypic changes (Choi & Friso, 2010). For example, using Mendelian randomization 
(MR) analysis to strengthen causal inference, Binder and Michels (2013) found that maternal 
folate levels affect epigenome-wide DNAm patterns in infant cord blood and that genes in 
close proximity to several CpG loci were involved in metabolic processing. Different types of 
prenatal diet have been examined in relation to offspring DNAm.  
On the one end of the spectrum is under-nutrition. In perhaps the first study to 
contribute empirical support for the hypothesis that early dietary conditions can cause 
persistent epigenetic changes in humans, Heijmans et al. (2008) examined DNAm (whole 
blood) in survivors of the Dutch hunger winter, a severe famine at the end of World War II. 
Even 60 years after the event, siblings who had been prenatally exposed to the famine 
showed lower DNAm of the IGF2 gene (implicated in foetal development) compared with 
their unexposed, same-sex sibling. As an extension to this study, Tobi, Heijman and 
colleagues (2014) examined a subset of the same siblings using a hypothesis-free, 
epigenome-wide approach. The researchers identified additional loci associated with prenatal 
famine exposure, including INSR (involved in prenatal growth and insulin signalling) and 
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CPTA1 (involved in fatty acid oxidation). In turn, these changes associated with relevant 
developmental outcomes, including birth weight and low-density lipoprotein cholesterol 
levels. Using data from the multi-generational Barbados Nutrition Study, Peter et al. (2016) 
examined whole blood from adults in their fifth decade of life (n = 94), including a group  (n 
= 44) who had been hospitalised in early infancy due to severe protein-energy malnutrition. 
Epigenome-wide DNAm analyses identified 134 nutrition-sensitive, differentially methylated 
genomic regions, including loci annotated to a number of neuropsychiatric risk genes (e.g. 
COMT, IFNG, SYNGAP1, and VIPR2), which in turn associated with cognitive outcomes (i.e. 
IQ and attention). Of note, less than 3% of loci in the adults showed DNAm in their children. 
This result could reflect a low rate of intergenerational transmission of DNAm patterns 
associated with early nutrition. It could also be due to the Illumina 450k technology not being 
sufficient to detect such changes (e.g. not annotating key intragenic regions); or due to factors 
experienced (e.g. improved nutrition) by the second generation that could normalise DNAm 
levels (see Szutorisz & Hurd, 2016). Related to this last point, both the Dutch Hunger Winter 
and the Barbados studies were retrospective in terms of later measures of DNAm (> 50 years) 
being associated with earlier measures of the nutritional environment. Drawbacks to 
retrospective studies include that it is difficult to establish the temporal relationship between 
events and to control for potential confounding factors (e.g. cohort effects; see Talati, Keyes, 
& Hasin, 2016) that can affect DNAm levels. 
 On the other end of the spectrum is over-nutrition, which can be indexed by obesity. 
Greater adiposity during pregnancy (either as a result of being more overweight at the start, 
or by gaining weight during pregnancy) can deliver greater concentrations of glucose, fatty 
acids and inflammatory markers to the developing fetus (Lawlor et al., 2007; Poston, 2012). 
Obesity-focused studies during pregnancy have typically utilised prospective research 
designs. Godfrey et al. (2011) examined DNAm in healthy neonates, focusing on 68 CpGs 
across five candidate genes for obesity (measured in cord blood). Differential DNAm in the 
vicinity of two genes – RXRA and eNOS – associated with child fat mass at age 9. DNAm in 
RXRA also associated with maternal prenatal diet, a result that was replicated in an 
independent sample. Based on 1018 mother-child pairs in the Accessible Resource for 
Integrated Epigenomic Studies (ARIES; Relton et al., 2015) – a subsample of the Avon 
Longitudinal Study of Parents and Children (ALSPAC) – Sharp et al. (2015) examined 
associations between prenatal maternal weight and neonatal epigenome-wide DNAm patterns 
(measured in cord blood). Compared to ‘normal’ weight mothers, offspring of overweight 
mothers and underweight mothers showed many more differentially epigenome-wide 
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methylated sites (underweight n=28; overweight n = 1621). Of interest, offspring of 
overweight and underweight mothers showed no overlap in loci at the epigenome-wide level. 
Using a negative control design to strengthen causal inference, the authors additionally found 
that epigenetic changes associated with maternal obesity were stronger than for paternal 
obesity, supporting an intrauterine environmental effect of nutritional status on DNAm. 
Studies have also investigated the effect of postnatal dietary patterns on children’s DNAm 
(Zheng, Xiao, Zhang, & Yu, 2014). One candidate gene study by Obermann-Borst et al. 
(2013), based on whole blood draws from offspring at 17 months of age, found that longer 
breastfeeding duration associated with lower levels of infant LEP methylation. As discussed 
by the authors, higher leptin levels can associate with deficient appetite regulation and risk 
for obesity. 
  Exposure to toxins. In general, prenatal exposure to bioactive compounds found in 
cigarettes, such as arsenic and lead, have been shown to affect DNAm patterns in neonates 
(Cardenas et al., 2015; Sen et al., 2015). In the field of epigenetics, the association between 
tobacco smoke exposure (whether directly or via prenatal exposure) and DNAm is perhaps 
the most extensively replicated finding. Similar to studies on obesity, toxin-focused 
epigenetic studies have primarily utilised prospective research designs. One of the earliest 
reports came from Breton et al. (2009), who found lower levels of global (LINE-1 and 
AluYb8) and CpG-specific methylation (Illumina GoldenGate Cancer methylation panel I 
measuring 1,505 CpGs) in buccal cells from children aged 5-7. Joubert et al. (2012) 
supported and extended these findings in the Norwegian Mother and Child Cohort Study 
(MoBA; n = 1,062 newborns, cord blood), by examining maternal plasma cotinine (a 
biomarker of smoking) in relation to a higher number of CpG sites (i.e. 473,844 via the 
Illumina 450k). The authors identified differential DNAm for 26 CpGs mapped to 10 genes, 
primarily involved in the detoxification of chemicals found in tobacco smoke. Of note, 
similar DNAm levels of the AHRR, CYP1A1 and GFI1 genes were found when using plasma 
cotinine vs maternal self-reports, and results were also replicated in the Newborn Epigenetics 
Study (Hoyo et al., 2011).  In 800 mother-child pairs from ALSPAC, Richmond et al. (2015), 
replicated many of these loci, as well as extending findings by examining how these 
methylation patterns change over time (cord blood at birth; whole blood at age 7 and 17). The 
authors reported that between birth and age 17, sites annotated to a number of genes showed 
reversible methylation (e.g. GFL1), whereas other showed persistently perturbed patterns 
(e.g. CYP1A1, AHRR). In summary, findings by Richmond et al. (2015), Breton et al. (2009) 
and Joubert et al. (2012) all converge in showing that prenatal exposure to teratogens can 
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have a prospective long-term impact on the methylome.  
  Early life stress and adversity. Stress and adversity are frequently assessed risk 
factors both during pregnancy and after. In animal models, prenatal and postnatal stress can 
cause long-term elevations in hypothalamic–pituitary axis (HPA) reactivity and anxiety-like 
behaviours, which can be explained by in part altered NR3C1 (glucocorticoid receptor) gene 
expression (Weaver et al., 2004). These findings have been validated by associational studies 
in living humans based on peripheral tissues. For example, NR3C1 DNAm in the offspring 
has been associated with prenatal factors including maternal depression and anxiety based on 
cord blood at birth (Hompes et al., 2013; Oberlander et al., 2008), as well as postnatal factors, 
such as frequency of mothers’ stroking of the child based on saliva in infancy (i.e. 14 months; 
Murgatroyd, Quinn, Sharp, Pickles, & Hill, 2015). As Murgatroyd et al. (2015) points out, 
candidate gene studies on NR3C1 methylation have generated similar results in brain, saliva, 
and blood samples, supporting the idea that early life adversities can influence DNAm 
patterns across a variety of tissues. 
Epigenome-wide changes in DNAm have also been investigated in relation to prenatal 
maternal stress. Of interest, these studies typically do not identify significant NR3C1 changes 
after multiple correction. Cao-Lei et al. (2014) examined DNAm patterns (via whole blood 
draws) in children (n =34) of women who, 13 years earlier, were pregnant during the 1998 
Quebec ice storm. Here, prenatal maternal objective stress (e.g. injury, days without 
electricity/in shelter) was associated with offspring DNAm at 1,675 CpG sites (from the 
Illumina 450k), spanning 957 genes primarily related to immune function. Subjective stress 
(i.e. perceived impact of events) was uncorrelated with DNAm. Results were validated (10 of 
12 loci investigated) within the same youth using pyrosequencing. In collaboration with 
Rijlaarsdam et al. (2016), we examined the prospective association between prenatal 
exposure to a general index of maternal stress and offspring epigenome-wide cord blood 
methylation in Generation R cohort (n = 912) and in ALSPAC (n = 828). A meta-analysis of 
results between the two studies indicated an over-representation of the methyltransferase 
activity pathway, although none of the individual DNAm loci identified survived genome-
wide correction. Of note, the prenatal measure of maternal stress employed by Generation R 
and ALSPAC contain both objective (e.g. housing adequacy) and subjective (e.g. emotional 
support) measures of stress, which may (in part) explain the discrepancies in results between 
Cao-Lei et al. (2014) and Rijlaarsdam et al. (2016). 
With regard to postnatal influences, early exposure to poverty and adversity in 
community samples has been associated with altered DNAm in large-scale hypothesis free 
 DNAm and child psychopathology - 12 
analytic approaches. For example, retrospective studies, based on whole blood draws in 
adolescence and adulthood, have implicated genes involved in basic cell processes, such as 
the protocadherin superfamily of genes encodes proteins involved in cell–cell adhesion and 
communication, as well as EUROG1, a gene that is involved in neuronal differentiation and 
cell-type specification in the developing nervous system (Borghol et al., 2012; Essex et al., 
2013). In addition, ‘natural experiments’ have been used as a powerful method for examining 
epigenetic changes following exposure to severe environmental conditions (Mill & Heijmans, 
2013). For example, research suggests that children raised in institutions (orphanages), who 
are deprived of normative rearing experiences, show changes in DNAm patterns that may be 
important for development and wellbeing (see Kumsta et al., 2016). In a Russian sample, 
Naumova et al. (2012) found that children raised in an institution since birth (n = 14) showed 
higher epigenome-wide DNAm patterns compared to high-poverty children living with their 
families (n = 14), particularly in genes related to immune regulation and cellular signalling. 
Blood samples were taken between 7-10 years of age and DNAm was assessed with the 
Illumina 27k. In another study, Esposito et al (2016) examined epigenome-wide DNAm 
(whole blood; Illumina 450k) in a sample of Russian and Eastern European adopted children 
(n = 50) compared with matched non-adopted children (n = 33). The authors identified 30 
differentially methylated sites spanning 19 genes enriched for neural development and 
developmental biology. Of interest, one of the genes, CYP1A1 (part of the cytochrome P450 
family), had previously been associated with prenatal smoking (e.g. Richmond et al. 2015), 
perhaps reflecting early life exposure to cigarette smoke. A third epigenome-wide study by 
Kumsta et al. (2016) compared Romanian adoptees exposed to either extended (6–43 
months; n = 16) or limited duration (<6 months; n = 17) early-life deprivation, in addition to 
a matched sample of UK adoptees (n=16) not exposed to deprivation. Although no probes 
were significant at the genome-wide level, an exposure-associated differentially methylated 
region was identified that spanned 9 sequential CpG sites in the promoter-regulatory region 
of the CYP2E1 gene.   
While there are some similarities in findings across these three ‘institutional’ studies 
(e.g. methylation markers involved in (neuro-)development and cell communication), 
differences in results might be attributable to a range of factors including the use of diverse 
cell types (buccal, whole blood or white blood cells), methylation assays (MeDIP, Illumina 
27k or 450k), measures of postnatal adversity (socio-economic position as measured via 
father’s occupation and household amenities; parental adversity measured via depressive 
symptoms, anger, role overload and financial stress; institutional deprivation; adoption), 
 DNAm and child psychopathology - 13 
timing of exposure (at age 7; during infancy and preschool; before 6 months of age) or 
sample size (ranging between n = 14 per group to n=109).   
  Another severe form of adversity, childhood maltreatment (e.g. abuse, neglect), has 
also been found to associate with DNAm alterations in genes important for stress-response, 
immune function and neurodevelopment (see Lutz & Turecki, 2014, for a review). With few 
exceptions, most published research to date on maltreatment has focused on candidate genes 
(e.g NR3C1, SLC6A4, FKBP5, BDNF and 5-HTT) and been retrospective in nature (see 
Beach, Brody, Todorov, Gunter, & Philibert, 2010; Turecki & Meaney, 2016). Yang et al., 
(2013) examined DNAm differences (saliva; Illumina 450k) in 96 children who were 
removed from parental care due to reports of abuse or neglect vs 96 children with no history 
of abuse (age range 5-14 years). After controlling for multiple comparisons, maltreated and 
control children showed significantly different methylation levels across 2,868 CpG sites, 
which contained numerous markers of physical and psychiatric morbidity (e.g. CCDC85, 
PTPRN). More recently, based on a cross-sectional sample of high-risk youth  (buccal cells; 
n = 124; age range = 16-24), we sought to characterise the DNAm ‘signatures’ of different 
forms of maltreatment, using an epigenome-wide approach (Cecil, Smith, et al., 2016). We 
found that physical maltreatment showed the strongest associations with DNAm, implicating 
multiple genes previously associated with psychiatric and physical disorders (e.g. GABBR1, 
GRIN2D, CACNA2D4, PSEN2). Based on gene ontology analyses, we also found that 
different types of maltreatment showed unique methylation patterns enriched for specific 
biological processes (e.g. physical abuse and cardiovascular function vs physical neglect and 
nutrient metabolism), but also shared a ‘common’ epigenetic signature enriched for biological 
processes related to regulation of nervous system development and organismal growth. 
Although the experience of victimization outside of the family is also important, it is a 
considerably under-researched area. One candidate gene study in 28 monozygotic twin pairs 
discordant for bullying victimization found that the bullied twins showed increased 
prospective 5-HTTPLR DNAm between ages 5 and 10 (Ouellet-Morin et al., 2013). It is 
noteworthy that most of these studies overlap little with respect to the risk measure (abuse, 
neglect, bullying), sample design (population vs twin) and genetic coverage (candidate vs 
epigenome-wide), providing limited opportunity to derive integrative conclusions. Of 
interest, the genome-wide loci identified by Yang et al. and Cecil et al. did not show strong 
overlap, which may be due to differences in the study samples (i.e. children with an ‘official’ 
history of maltreatment vs. self-reports from high risk youth), and the different age ranges of 
the study participants (i.e. 5-14 vs. 16-24 years of age). In future, efforts to maximise 
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comparability between studies will hopefully allow a deeper insight into the epigenetic 
specifics of maltreatment characteristics. 
Summary. In support of the a path of the mediation model (Figure 2 panel A; risk 
exposureDNAm), DNAm has been associated with a range of pre- and postnatal 
adversities. Whereas prenatal studies have generally been prospective, postnatal studies, 
especially those examining early nutrition and childhood maltreatment, have been 
retrospective and/or cross-sectional. In reminder, to test DNAm as a mediator, the risk 
exposure should come before DNAm (e.g., prenatal risk  DNAm at birth). In addition, only 
a handful of studies have replicated findings in an independent sample (e.g. Godfrey et al., 
2011), integrated genetic information or used methods to strengthen causal inference (e.g. 
MR: Binder & Michels, 2013; negative control: Sharp et al., 2015; twin discordance: Oullet-
Morin et al., 2013).  
 
 DNAm and child psychopathology: the b path 
In this section, we review studies that have examined DNAm in relation to psychopathology 
from childhood through to adolescence (i.e. the b path), including internalising and 
externalising difficulties.  
Internalising difficulties. Research on childhood internalising problems has primarily 
focussed on DNAm of NR3C1. In a cross-sectional analysis of high-risk pre-schoolers, 
Parade et al. (2016) found that higher DNAm levels at exons 1D and 1F (extracted from 
saliva) associated with higher internalising – but not externalising – behaviour problems. 
Consistent with this, Dadds, Moul, Hawes, Mendoza Diaz, and Brennan (2015) reported that 
increased DNAm in the 1F region across whole blood and saliva associated with morning 
cortisol levels and higher risk of co-occurring internalising problems among clinically 
referred conduct disordered children. Furthermore, NR3C1 methylation (extracted from 
whole blood) has been found to positively associate with risk of a lifetime diagnosis of 
internalizing disorders in an adolescent population sample (van der Knaap, Oldehinkel, 
Verhulst, van Oort, & Riese, 2015). Taking an epigenome-wide approach, Weder et al. 
(2014) reported that saliva-derived DNAm in three genes involved in stress response and 
neural plasticity (ID3, TPPP, and GRIN1) associated with child depression levels. Nominal 
associations were also identified in a number of traditional candidate genes, including 
NR3C1, FKBP5 and BDNF – particularly among children exposed to maltreatment. Finally, 
capitalizing on a genetically-sensitive design, Dempster et al. (2014) examined epigenome-
wide patterns in 18 monozygotic twin pairs discordant for adolescent depression, based on 
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buccal cell DNA. The most differentially methylated site, annotated to STK32C (a 
serine/threonine kinase gene), was also found to be independently associated with major 
depression in post-mortem cerebellum samples, suggesting that, despite tissue specificity in 
DNAm, some disease epimutations may be detectable across multiple tissues – consistent 
with prior findings (e.g. Davies et al., 2012). Likewise, the consistency of some findings 
(such as NR3C1) across studies is remarkable considering the heterogeneity of study 
characteristics (e.g. blood vs saliva; population vs twin samples; preschool age vs 
adolescence; children with or without a history of maltreatment or co-occurring externalizing 
symptoms). The moderate degree of stability in results related to NR3C1 might originate from 
a slight increase in sample size ranging from n = 171 to n = 361 (compared to – for instance – 
a range of n = 14 – n = 109 in studies on postnatal adversity, as discussed above).  
Overall, the candidate gene studies described above support a link between higher 
NR3C1 methylation and internalising difficulties, with associations observed across different 
peripheral tissues and sample characteristics. However, NR3C1 methylation does not emerge 
as a significant predictor of internalising difficulties based on existing epigenome-wide 
studies, suggesting that – if associations are indeed true – they are likely to be of small effect 
size. As commonly observed in epigenome-wide association studies (EWAS), the two studies 
that employed an EWAS approach did not identify overlapping DNAm sites. While both 
studies extracted DNA from similar sources (saliva/buccal cells), used the same array 
(Illumina 450k) and examined depression specifically, the studies differed in sample 
characteristics (children differing in maltreatment exposure vs monozygotic twins discordant 
for depression) and analytical strategies (linear mixed effects model vs in-house method 
combining significance level and effect size), which may have contributed to the divergent 
findings. Of note, because EWAS studies do not typically publish their full results as 
supplementary material, it is not possible to establish whether DNAm sites identified in one 
study may show sub-threshold associations in other studies.  
Externalising difficulties. A larger number of studies have investigated DNAm 
patterns associated with externalising difficulties, including physical aggression and conduct 
problems (CP), callous-unemotional (CU) traits, attention deficit hyperactivity disorder 
(ADHD), oppositional defiant disorder (ODD) and substance use.  
  Physical aggression and conduct problems. In contrast to higher DNAm reported for 
internalising problems, Heinrich et al. (2015) found that youth with a lifetime diagnosis of an 
externalising disorder showed lower levels of NR3C1 methylation at exon 1F (whole blood), 
compared to both youth with a depressive disorder and healthy controls. Based on data 
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extracted from white blood cells, one research group also found that, compared to controls, 
adult males with a history of chronic childhood aggression differed in (i) SLC6A4 promoter 
methylation and in vivo levels of brain serotonin synthesis (Wang et al., 2012); (ii) DNAm 
levels in a set of genes involved in cytokine function and inflammation (Provençal, 
Suderman, Vitaro, Szyf, & Tremblay, 2013), and (iii) DNAm patterns across a large number 
of gene promoter regions in an epigenome-wide scan (Provençal et al., 2014) – a finding that 
was later extended to a small sample of adult females as well (Guillemin et al., 2014). In the 
ALSPAC sample, we found that methylomic variation at seven loci across the genome at 
birth (cord blood) differentiated children who go on to develop early-onset (n = 174) vs low 
(n = 86) conduct problems, including sites in the vicinity of MGLL – a gene involved in 
endocannabinoid signalling and pain perception.(Cecil, Jaffee, et al., 2016). In addition, sub-
threshold associations with DNAm sites across three candidate genes (MAOA, BDNF, 
FKBP5) were identified, supporting the idea that DNAm patterns in candidate genes may 
reliably associate with psychopathological outcomes, but only exert small-to-moderate effects 
that do not survive genome-wide correction. Finally, we examined whether the identified loci 
associated with genetic and environmental risks. As our sample was underpowered to 
examine genetic polymorphisms directly, we consulted an online catalogue of known 
methylation quantitative trait loci (mQTL) based on the Illumina 450k resource in ARIES 
(Gaunt et al., 2016). None of the identified loci were linked to known mQTLs, although 
nominal associations with prenatal exposures were observed (e.g. maternal smoking and 
alcohol use).  
Callous-unemotional traits. In a clinical sample of boys diagnosed with conduct and 
oppositional defiant disorders, those with more severe CU traits (e.g. low capacity for 
empathy, lack of guilt, shallow affect) have been reported to show  lower levels of HTR1B 
methylation in saliva (Moul, Dobson-Stone, Brennan, Hawes, & Dadds, 2015), as well as 
higher OXTR methylation in blood, which in turn correlated with lower circulating oxytocin 
levels (Dadds et al., 2014), compared to boys with less severe CU traits.  Using a genome-
wide approach in ARIES, we examined DNAm patterns associated with a correlate of CU 
traits – low prosocial behaviour (e.g. inconsiderate of other’s feelings, not helpful if someone 
is hurt; Meehan et al., 2017). We found that, at birth (cord blood), two loci located in the 
vicinity of NDUFS8 and SGCE/PEG10 differentiated chronic-low prosocial youth from 
typical comparisons. In turn, higher DNAm in SGCE/PEG10 associated with lower empathy, 
higher social-cognitive difficulties and greater victimization during childhood.  
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Attention deficit hyperactivity. On the basis of findings from animal and molecular 
genetic work, there has been growing interest in the involvement of dopamine signalling 
genes in ADHD development. In a sample of Chinese Han children, Xu et al. (2015) found 
that promoter DNAm and expression levels of the dopamine genes DAT1, DRD4 and DRD5 
related to ADHD risk. Consistent with this, Dadds, Schollar-Root, Lenroot, Moul, and Hawes 
(2016) reported that higher DRD4 methylation related to more severe ADHD 
symptomatology in high-risk children across peripheral tissues (saliva and blood). 
Interestingly, these associations were found to be specific to the attentional features of 
ADHD, and were independent of genetic variation, environmental adversity and comorbid 
conduct problems. However, based on another sample of Chinese Han children with a 
diagnosis of ADHD, Ding et al. (2016) found no evidence for a significant association 
between DAT1 or DRD4 promoter methylation and baseline ADHD symptoms, although 
DAT1 (but not DRD4) methylation did correlate with response to methylphenidate treatment 
at follow-up. Focusing on a different candidate gene in 6-15 year olds with ADHD, Park et 
al. (2015) found that increased SLC6A4 promoter methylation specifically associated with 
more severe hyperactive-impulsive symptoms, as well as lower cortical thickness in occipital-
temporal regions.   Using the prospective Generation R cohort, van Mil et al. (2014) 
examined associations between DNAm in 7 candidate genes (measured in cord blood at birth) 
with ADHD symptoms (at age 6). DNAm levels were inversely related to ADHD symptoms, 
with the DRD4 and SLC6A4 regions largely explaining this association. Supporting evidence 
for a role of altered neurotransmitter function has also emerged from an epigenome-wide 
study of ADHD in 7-12 year old children. After filtering genes based on statistical and 
biological criteria, Wilmot et al (2016) found that DNAm of the neuropeptide receptor gene 
VIPR2 in saliva was lower in the ADHD group vs controls (all boys), and this association 
was confirmed in an independent sample of age-matched children. At a broader level, genes 
that were nominally associated with ADHD were found to be enriched for biological 
processes related to inflammation and monoamine neurotransmission. Finally, using ARIES, 
we performed a epigenome-wide study of DNAm (cord blood at birth; whole blood at age 7) 
and trajectories of ADHD (ages 7-15) (Walton et al., 2016). DNAm at birth differentially 
associated with a high vs low ADHD trajectory across 13 probes, including those annotated 
to ZNF544 (previously implicated in ADHD) and PEX2 (related to fatty acid metabolism of 
n-3 PUFAs and axon myelination). None of the 13 probes maintained an association with 
ADHD at age 7, which suggests that DNAm associations can be time- specific, perhaps 
reflecting critical – or sensitive – periods of development. Together, tentative evidence from 
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epigenetic studies on ADHD points to the potential relevance of DNAm alterations in genes 
implicated in neurotransmission, particularly dopaminergic signalling.    
Oppositional defiant disorder and ADHD.  Twin studies suggest that externalising 
disorders, such as ODD and ADHD, share considerable common genetic variance (Barker, 
Cecil, Walton, & Meehan, 2017); however,  the potential role of DNAm in  this common 
biologic variability is unclear. Based on ARIES, we (Barker, Cecil, Walton, Jaffee, et al., 
2017) investigated (i) prospective associations between neonatal DNAm (cord blood) and 
trajectories (ages 7-13) of ODD symptoms, as well as the ODD sub-dimensions of Irritable 
and Headstrong; and (ii) biological overlap with the ADHD-associated loci identified by 
Walton et al. (2016).  We identified a larger number of loci in relation to ODD as a whole (n 
= 30) compared to either the sub-dimension of Headstrong (n = 11) or Irritable (no loci) 
alone.  Overlap analysis also indicated shared biological influences between ODD and 
ADHD, including glutamate signalling and the protocadherin superfamily of genes involved 
in cell–cell adhesion and communication, a result similar to a study that examined the impact 
of early poverty on DNAm (Borghol et al., 2012). We also examined potential genetic 
influences on DNAm through the use of the mQTLdb database. Three of the 30 loci for ODD 
and two of the 11 loci for Headstrong associated with known mQTLs (i.e. DNAm loci that are 
likely to be under genetic control).   
  Substance use. Finally, very little work has sought to characterize the relationship 
between DNAm and substance abuse during adolescence (Cecil, Walton & Viding, 2015). 
Researching COMT methylation in whole blood – an important gene for neurotransmitter 
catalysis – Van der Knaap et al. (2014) found no main effect on adolescent cannabis use. 
However, a significant methylation by genotype interaction was identified, where Met/Met 
carriers with higher DNAm were least likely to be frequent cannabis users. (Philibert, Gunter, 
Beach, Brody, & Madan, 2008) reported that DNAm in MAOA (derived from lymphoblast 
lines) significantly associated with alcohol and nicotine dependence for females, but not 
males – also showing a trend-level effect of genotype on DNAm in the female group. A study 
by Ruggeri et al. (2015) examined epigenome-wide DNAm differences (whole blood) in 
monozygotic twin pairs discordant for alcohol use disorders in young adulthood. The most 
differentially methylated region was located in PPM1G, a gene previously linked to alcohol 
dependence. This association was verified technically using mass spectrometry and replicated 
in an independent sample of 499 adolescents from the IMAGEN cohort, whereby higher 
DNAm associated with decreased gene expression (independently of genotype), early 
escalation of alcohol use and greater impulsiveness, as well as increased blood-oxygen-level-
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dependent response in the right subthalamic nucleus during an impulsiveness task. While is 
not possible to compare these three studies given their different objectives, level of coverage 
(candidate gene vs EWAS) and substance type examined (cannabis, nicotine, alcohol use), it 
is noteworthy that all sought to account for genetic influences, with Ruggeri et al (2015) also 
featuring an independent replication and the integration of DNAm with additional biological 
data (i.e. gene expression and brain imaging).   
Summary. Overall, the majority of studies on the b path of the mediation model 
(Figure 2 panel A; DNAm  psychopathology) were retrospective and focussed on candidate 
genes (particularly those implicated in stress response and neurotransmitter function), 
although an increasing number of longitudinal, epigenome-wide investigations are emerging. 
As with the a path, only a few studies, such as Ruggeri et al., 2015, have replicated findings 
in an independent cohort (e.g.), accounted for genetic influences and/or used advanced 
methods for causal inference (e.g. twin discordance: Dempster et al., 2014). However, a 
handful of studies have taken steps to biologically characterise the identified DNAm changes 
by testing whether effects replicated across peripheral tissues, correlated with gene product 
levels, or were associated with measures of brain activity (e.g. multiple tissues: Dadds et al., 
2016; gene product levels: Dadds et al., 2014; brain activity: Ruggeri et al., 2015). Similarly 
to the a path section reviewed above, genes investigated by candidate studies did not 
converge with those identified by studies that used a hypothesis-free, epigenome-wide 
analyses. Furthermore, little or no overlap was evident in top DNAm sites identified across 
epigenome-wide analyses of psychopathology. Together, these discrepancies are likely due to 
wide methodological differences across studies, including sample characteristics (e.g. age, 
risk level), phenotype operationalisation (e.g. symptom-based vs clinical threshold), and 
analytical strategy (e.g. choice of covariates, pruning of DNAm sites and statistical models 
performed). The discordance between candidate gene studies and EWAS studies may also 
reflect differences in effect sizes of the identified sites. 
 
Integrative models:  
Combining risk exposure, DNAm and child psychopathology 
In this section, we highlight four studies that have explicitly tested whether DNAm 
mediates associations between risk exposures and psychopathology. Specifically, these are 
studies that have integrated environmental, epigenetic and phenotypic measures, using a 
prospective design that captures the temporal ordering of the variables, with DNAm as the 
intermediary variable (i.e. riskDNAmpsychopathology).  
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First, Monk et al. (2016) examined whether mothers (n = 61) with higher levels of 
stress or depressed mood in the 2nd trimester of pregnancy showed lower levels of foetal 
coupling – an index of foetal nervous system development – in the third trimester, due to 
DNAm in three placental glucocorticoid pathway genes – HSD11B2, NR3C1 and FKBP5. 
Maternal DNAm was measured by saliva and results were validated in placental tissue. The 
authors found that mothers who reported higher rates of depression had higher HSD11B2 
methylation, which in turn, associated with lower foetal coupling.  
Second, in a sample of CP youth from ALSPAC, we examined whether different 
developmental pathways to callous-unemotional traits exist, based on the presence (n = 45) or 
absence (n = 39) of co-occurring internalising symptoms (Cecil et al., 2014).  Specifically, 
we used path analysis to trace the prospective inter-relationships between environmental risk 
(prenatal-to-age 9) and OXTR DNAm (birth, age 7 and 9) in the prediction of CU traits (age 
13), for CP youth who either showed high or low levels of internalising problems. For those 
with low levels of internalising problems, higher prenatal risks (maternal psychopathology, 
criminal behaviours, substance use) associated with higher OXTR methylation at birth, which, 
in turn, associated with higher CU traits in early adolescence. Intriguingly, we also identified 
in this group an “evocative epigenetic-environment correlation”, whereby higher OXTR 
methylation at birth (but not at any other time point) was prospectively associated with lower 
subsequent experience of victimization during childhood (birth-age 7). In contrast, no 
associations between OXTR methylation and CU traits was identified in youth with high 
internalising problems.  
Third, applying a similar analytical model in ALSPAC, we examined the degree to 
which a high-fat, high-sugar diet (maternal: prenatal; child: age 3) might associate with 
higher ADHD symptoms for children with early-onset (n = 83) vs low CP (n = 81) 
(Rijlaarsdam et al., 2017). Results indicated that, across both groups, prenatal diet associated 
with higher IGF2 methylation at birth. However, only in the early-onset CP group, higher 
IGF2 methylation also associated higher ADHD symptoms. Similar to the Cecil et al., (2014) 
study, epigenetic associations were localised at birth (i.e. no associations with DNAm at age 
7).  
Finally, we again used the ALSPAC sample (n = 244) to investigate epigenome-wide, 
prospective associations between DNAm (birth, age 7) and substance use in adolescence 
(tobacco, alcohol and cannabis use; n = 244; age 14–18; Cecil, Walton, et al., 2016). We 
found that at birth (but not at age 7), epigenetic variation across a tightly interconnected 
genetic network (n = 65 epigenome-wide corrected loci) associated with greater levels of 
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substance use during adolescence, as well as an earlier age of onset amongst users. Key 
annotated genes included PACSIN1, NEUROD4 and NTRK2, implicated in 
neurodevelopmental processes. Several of the identified loci were associated with known 
methylation quantitative trait loci, and consequently likely to be under significant genetic 
control. In addition, we found evidence for a prenatal environmental effect, whereby these 65 
loci collectively mediated the influence of prenatal maternal tobacco smoking on adolescent 
substance use (see Figure 2, Panel B).  Although the above studies are promising, in that they 
show that DNAm can act as a mediator between risk exposure and child psychopathology, it 
is important to note that they are nonetheless associational in nature (i.e. non-causal).  
 
Discussion 
In this review, we summarised evidence linking environmental risk exposure, DNAm and 
childhood psychopathology. We focused on studies that have examined living children and 
adolescents (i.e. the measure of risk and/or psychopathology is in childhood or adolescence) 
and that have used DNAm extracted from peripheral tissues. Based on the studies presented, 
there is preliminary evidence to support that (i) pre- and postnatal environmental factors, such 
as diet, neurotoxic exposures and stress, may influence offspring DNAm (i.e. a path), and 
that (ii) variability in DNAm may, in turn, associate with internalising and externalising 
difficulties during childhood and adolescence (i.e. b path). Despite these promising findings, 
very few studies have examined DNAm in relation to both exposures and outcomes, only a 
handful have accounted for genetic confounding and most all analyses have been 
correlational in nature – to the best of our knowledge, models examining causal mediational 
pathways in living children and adolescents have yet to be published. Consequently, the 
extent to which DNAm may truly mediate environmental influences on the development and 
course of psychopathology is not clear. Below, we discuss five key areas that can help move 
the field forward. 
Key challenges, recommendations and future directions 
1. Characterizing environmental effects with greater precision (i.e. the a path) 
First, we need to reach a more complete and fine-tuned understanding of 
environmental effects on DNAm (see top third of Figure 3, the a path section). As seen 
earlier in our review, the number of reported associations between environmental influences 
and DNAm is exponentially growing, implicating a wide range of exposures. These 
exposures, however, are often correlated – for example, stress levels in pregnancy have been 
associated with quality of diet (Barker, Kirkham, Ng, & Jensen, 2013), and childhood 
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maltreatment has been found to cluster in geographical areas characterized by increased 
poverty and violence exposure (Cecil, Viding, Barker, Guiney, & McCrory, 2014). Yet, 
epigenetic studies to date have typically examined single exposures in isolation, potentially 
resulting in the overestimation of effects observed – in some cases, the risk under 
investigation may even be a proxy for unmeasured exposures (Monk, Georgieff, & 
Osterholm, 2013).  In future, modelling multiple exposures and/or outcomes simultaneously 
(e.g. via path analysis) may help to isolate specific risk pathways with greater accuracy, 
particularly in cases where an exposure has been found to associate with multiple negative 
outcomes (i.e. ‘multifinality’), or conversely, where an outcome has been linked to different 
exposures (i.e. 'equafinality'; Cicchetti & Rogosch, 1996).  
Furthermore, studies will need to begin testing the potential moderating role of 
exposure characteristics, such as type, severity, duration and timing (Barker, 2013). 
Specifically, studies that record this information should aim to address a number of 
outstanding questions, including (i) the extent to which epigenetic patterns may reliably 
differentiate between types of exposures (e.g. childhood abuse vs neglect); (ii) whether the 
effects of acute exposures differ from chronic ones; and (iii) whether environmental effects 
may be developmentally-dependent (e.g. pre- vs post-natal), for example, based on the degree 
of maturation/plasticity of relevant biological systems.   
Another factor that may contribute to the overestimation of effects is genetic 
influence. Research suggests that (i) genetic effects on DNAm can be highly stable across the 
life course, and (ii) the genetic component of DNAm may have an important role in the 
development of complex traits (Gaunt et al., 2016; Hannon et al., 2016). However, very few 
studies reviewed here have modelled genetic influences when examining the association 
between exposures and DNAm. In order to address this, future studies should seek to use 
genetically-informative designs that make it possible to isolate environmental influences (e.g. 
monozygotic twin difference design; Oullet-Morin et al., 2013) or incorporate genetic 
sequencing data in order to control for genetic variants known to influence DNAm levels. 
These mQTLs (Gaunt et al., 2016) have been found to associate with gene expression and 
may serve as markers for genetic influences on gene regulation (see Hannon et al., 2016). 
There are now online mQTL databases based on published large-scale analyses that can be 
used when genetic information is unavailable, or when studies are underpowered to perform 
genetic analyses (e.g. ARIES mQTL database; www.mqtldb.org; as done for example in 
Cecil et al., 2016). It should be noted that the heritability of DNAm patterns via twin studies 
(e.g. between 20-97% across different genes; Heijmans, Kremer, Tobi, Boomsma, & 
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Slagboom, 2007) is greater than what can currently be explained using known mQTLs (Gaunt 
et al., 2016). Therefore, the small amount of genetic influence identified in our research (e.g. 
Barker et al., 2017; Cecil et al., 2016, 2017) may underestimate genetic variance that could be 
due to polygenic effects, involving many mQTLs, each of explains a small amount of 
variance (as detectable in the ARIES resource given the phenotypes we examined). Another 
current limitation is that existing array platforms (e.g. 450k) may not provide representative 
data for methylomic variation and its underlying genetic architecture (Taudt, Colomé-Tatché, 
& Johannes, 2016). However, the introduction of newer array-based platforms, such as the 
EPIC array could help to more comprehensively assess genetic influences on DNAm (Taudt 
et al., 2016).  
2. Improving understanding of the methylome (i.e. the mediator) 
Another barrier to establishing causal mediation relates to our limited knowledge of 
DNAm itself (see Figure 3, the mediator section). We highlight here three aspects of DNAm 
that warrant further investigation. First, variability. Unlike the genome – which remains 
mostly stable across the lifespan – DNAm is dynamic over time and varies across multiple 
factors, including sex, age, tissue, and cell type (Liang & Cookson, 2014). Consequently, it 
has been difficult to establish what a ‘normative’ profile of DNAm is (as this may depend on 
when and where the sample is collected), and how far such profile must deviate in order to 
confer risk for psychopathology. To address this, it will be important to collect data across 
multiple tissues and time points. Specifically, the availability of cross-tissue data will make it 
possible to quantify peripheral-CNS variability (Walton et al., 2015) and locate peripheral 
biomarkers that most closely resemble DNAm patterns in neural networks underlying 
psychopathology. Establishing whether exposures of interest exert tissue-specific vs global 
effects will also be important, as this will bear on the selection of appropriate samples for 
testing mediation hypotheses. A notable example of this is NR3C1 methylation, which so far 
has been linked to early adversity across multiple peripheral (e.g. blood, saliva, placenta) and 
neural (e.g. hippocampus) tissues (see Turecki & Meaney, 2016).  At the same time, 
collection of repeated measures of DNAm – so far a rare occurrence (with notable 
exceptions, e.g. ARIES, Generation R) – will be crucial for establishing patterns of stability 
vs change in DNAm across development. Particularly, studies will need to investigate 
whether certain genomic regions are more dynamic than others (perhaps reflecting greater 
responsivity to the environment, or even gene-environment interactions on DNAm levels), 
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and whether longitudinal DNAm trajectories may be informative in predicting the onset and 
course of psychopathology.  
The second aspect is scale. At present, we are only able to access a small part of a 
much wider system that needs to be fully mapped out. Indeed, commonly used platforms such 
as the Illumina 450k only capture around 2% of methylomic variation across the genome. In 
turn, the methylome as a whole is only one of multiple epigenetic mechanisms that work in 
concert, including non-coding RNAs, histone modifications and other types of chromatin 
remodelling. As a result, many epigenetic patterns of potential relevance to psychopathology 
remain largely inaccessible (Non & Thayer, 2015). In the near future, rapid technological 
advances such as whole-genome bisulfite sequencing, will make it increasingly possible to 
obtain a more complete picture of the methylome. The compilation of large-scale reference 
epigenome datasets (e.g. BLUEPRINT; http://www.blueprint-epigenome.eu/) will also be 
important for establishing how DNAm fits within the broader machinery of epigenetic 
regulation (Shakya, O'Connell, & Ruskin, 2012).  
The third aspect is transmission. Although it is generally assumed that in the zygote 
patterns in DNAm are erased after fertilization – allowing for a complete epigenetic resetting 
in the offspring – recent studies in animals have shown that in some instances DNAm 
patterns are copied, providing a potential mechanism for transgenerational inheritance. For 
example, rodent studies have shown that environmental exposure to endocrine disruptors can 
lead to reduced spermatogenic capacities in the following four generations via altered DNAm 
patterns in the germ line (Anway, Cupp, Uzumcu, & Skinner, 2005). In humans, the 
possibility that exposure-related DNAm patterns may be passed on across generations has 
received considerable theoretical interest, and recent research suggests this possibility 
(Yehuda et al., 2016). However, at present, little empirical data exists. An intriguing question 
is whether an exposure can potentially affect DNAm patterns in three generations directly – 
without the DNAm patterns being inherited; e.g., a prenatal DNAm stress effect on the 
mother, foetus and, in turn, DNAm in the foetus’ germ cells (see Figure 3 on the left-hand 
side; Bowers & Yehuda, 2016). Testing hypotheses about transmission and epigenetic 
inheritance will require the collection of data spanning several generations, presenting 
perhaps one of our greatest challenges.  
3. Establishing the functional significance of identified loci (i.e. the b path) 
The next area for future research concerns the pathway between DNAm and 
psychopathology (see Figure 3: the b path section). As we have seen in this review, DNAm 
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patterns have been associated with a wide range of psychopathological outcomes in children 
and adolescents. However, the presence of an association alone does not necessarily imply a 
functional effect. Indeed, it is unclear to what extent statistical significance overlaps with 
functional significance. For example, reported effects are sometimes highly significant but 
involve only a small percent change in methylation, with unknown biological consequence. 
Furthermore, genes selected for candidate gene studies have not typically converged with 
those identified using hypothesis-free, epigenome-wide approaches. This is well illustrated in 
the case of NR3C1, which, despite being the most commonly investigated candidate gene in 
the field (with associations having been reported across tissues and species), is not usually 
identified in EWAS studies that employ epigenome-wide thresholds of significance.  
In order to move beyond statistical associations, researchers should, whenever possible, 
assess the functional significance of psychopathology-related DNAm changes at multiple 
biological levels (e.g. transcriptome, proteome, metabolome). Relevant strategies include (i) 
profiling gene expression and additional omics data from the same samples as the DNAm 
(e.g. Ruggeri et al., 2015); (ii) using animal models (e.g. which permit chemical alteration of 
DNAm patterns); and (iii) carrying out in vitro experiments (e.g. cell cultures).  In cases 
where this is not feasible, researchers may use online resources to check whether the 
identified DNAm loci overlap with established key regulatory elements, such as transcription 
factor binding sites (e.g. using ENCODE data; http://genome.ucsc.edu/ENCODE/; e.g. as 
done in Cecil et al., 2017; Provencal et al., 2013). In-vivo neuroimaging data could also be 
used in future to examine whether peripheral DNAm markers associate with structural and 
functional correlates of psychopathology (e.g. amygdala volume; Walton et al., 2017). 
Finally, in light of studies pointing to the temporal specificity of DNAm effects on 
psychopathology (e.g. our work pointing to localized effects at birth; Cecil et al., 2014; 
Rijslasdaam et al., 2016), more research is needed to determine whether DNAm can trigger 
developmental cascades, without the mark itself being sustained over time. More broadly, 
research will need to trace exactly how the downstream effects of DNAm engender biological 
vulnerability to psychopathology.  
4. Maximising comparability across studies and opportunities for replication 
DNAm studies to date have been highly heterogeneous, differing widely in the choice 
of design, sample characteristics, genomic coverage, quality control procedures, variables of 
interest and analytical routines. Consequently, comparability across findings has been low, 
and opportunities for replication scarce. Going forward, the establishment of best practice 
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guidelines will considerably help in this respect. Indeed, areas of consensus are already 
emerging (e.g. need for appropriate covariates), and standardized pipelines for data 
normalization and quality control are also increasingly available (Morris & Beck, 2015). 
Furthermore, the integration of discovery and replicate samples will become more important 
(e.g. as done in Godfrey et al., 2011; Ruggeri et al., 2015), as was the case for genomic 
studies.  
One main challenge to maximising comparability is that DNAm data are multifactorial, 
high dimensional, and inter-correlated, raising questions as to how best they should be 
analysed in the first place (Almouzni et al., 2014). In Figure 4 (left-hand side), we provide a 
flowchart of analytical approaches that may be undertaken, depending on study 
characteristics such as genomic coverage (i.e. epigenome-wide vs candidate-focussed), 
preferred level of analysis (i.e. single-site analysis vs application of data reduction strategies), 
availability of repeated DNAm measures, and access to both exposure and phenotype data. 
These include commonly-used approaches in the field, as well as methods that are likely to 
become increasingly applied in future, such as polyepigenetic scores and structural equation 
modelling.  
5. Strengthening causal inference 
Finally, we need to move towards stronger causal inference. It is important to note that 
a non-causal DNAm biomarker can satisfy steps for statistical significance in mediation (e.g. 
the a*b path). However, in order for DNAm to truly be a causal mediator, it must be shown 
to be causally affected by an exposure (a path), and to causally affect a psychopathological 
outcome (b path; Figure 2A). These pathways will be particularly difficult to isolate as (i) 
environmental influences are confounded by genetic factors; (ii) epigenetic effects are 
complex and inter-correlated; and (iii) psychopathological outcomes are heterogeneous and 
multi-determined. One key issue here is reverse causation, whereby the observed DNAm 
changes may be a consequence – as opposed to a risk factor for – psychopathology. This can 
be partially addressed by using a prospective design that accurately captures temporal order, 
especially in the case where the availability of repeated measures data makes it possible to 
trace longitudinal interrelationships between risk exposures, DNAm and psychopathology.   
Even so, correlational studies in general are vulnerable to confounding, and it will 
become increasingly important to establish the robustness of findings using advanced 
inference methods. Ideally, studies should aim to draw on multiple approaches to test causal 
pathways (i.e. triangulation; Lawlor, Tilling, & Smith, 2017), as each has its own strengths 
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and limitations (see right-hand side of Figure 4 for an overview). For example, studies may 
use a mixture of natural experiments (e.g. negative control, Sharp et al., 2015; mendellian 
randomization; Relton & Davey Smith, 2012) and methodological approaches (e.g. cross-
setting and cross-species comparisons). For a comprehensive review of methodological 
approaches for drawing causal inferences from epidemiological birth cohorts, we refer the 
reader to Richmond et al (2014). It is important to note that peripheral DNAm marks may 
still be a useful biomarker, even in the absence of causal effects (see Ladd-Acosta & Fallin, 
2015). As stated, in cancer research, epigenetic biomarkers have even been used to predict 
treatment response. However, without a causal relationship, any type of ‘epigenetic therapy’ 
(e.g. Syzf, 2015) will be unlikely to have an effect on the psychopathological outcome.  
 
Implications and translational potential 
DNA methylation is a promising molecular mechanism by which the environment can 
increase risk for psychopathology. Yet, as we gain an appreciation of the challenges 
characterizing epigenetic research, we must be mindful to manage expectations. In future, the 
use of strategies such as careful selection of research design (e.g. appropriate tissue, sample 
size, time points), collection of prospective and integrative data, functional characterization 
of epigenetic findings, transparency in reporting and replication, and the application of causal 
inference methods, will mark an important step for overcoming current hurdles and moving 
the field forward. Bearing this in mind, there are a number of ways in which epigenetic 
research may contribute to the understanding, prevention, and treatment of psychopathology.  
In the short-term, findings may be used to refine existing models of how environmental 
influences become biologically embedded, shifting developmental trajectories and 
engendering latent vulnerability for psychopathology. Longitudinal models may also be used 
to investigate the timing of environmental effects and pinpoint specific windows of biological 
vulnerability (e.g. prenatal period, infancy) that could benefit most from preventive action. In 
the medium-term, as the number of replications grow and robust associations are identified, 
epigenetic variation in specific genes may be used across clinical and research settings as 
biomarkers for environmental exposures, psychopathology risk, and response to treatment. 
Furthermore, the comparison of DNAm pre- vs post-intervention (e.g. via environmental 
enrichment, psychological therapy, medication), could lend insights into the potential 
reversibility of psychopathology-related patterns and how best to promote resilience. Indeed, 
tentative evidence that psychopathology-related DNAm patterns respond to psychological 
and pharmaceutical intervention is already beginning to emerge (Ding et al., 2016; Roberts et 
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al., 2014). In the long-term, establishing causal pathways between DNAm and 
psychopathology knowledge may provide greater knowledge about the aetiology of child and 
adolescent psychopathology, and perhaps even lead to the development of novel strategies for 
treating mental health problems. 
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Figure 1. Published human studies (2000-2016) relating DNAm to environmental exposures 
(blue) or psychopathology-related phenotypes (red) 
 
Note. Lines represent search terms on SCOPUS. Blue lines = a path (exposure). Red Lines = b path 
(psychopathology). Solid lines = general terms including any study across age and research design 
(children and adults; cross sectional and longitudinal). Wide dots = additionally specify child studies 
across designs. Small dots = narrow search specifying childhood and longitudinal.  
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Figure 2. Mediation model reviewed in this article 
 
A. The conceptual mediation model reviewed in this article, whereby the independent variable (X) is the pre- 
and post-natal environment (e.g. toxic exposures, stress, diet); the mediator variable (M) is DNAm extracted 
from peripheral tissues in living subjects; and the dependent variable (Y) is developmental psychopathology, 
including internalising and externalising difficulties in childhood and adolescence. Of note, both the a path and 
the b path may be moderated by genetic effects. B. An empirical example of the mediation model, adapted from 
Cecil et al. (2016) with permission from Translational Psychiatry. Specifically, the model shows that, over and 
above other prenatal risk factors, maternal smoking prospectively associates with variation in DNAm at birth 
(measured as a cumulative risk index encompassing 65 genome-wide corrected loci), which in turn associates 
with greater substance use in adolescence (tobacco, alcohol and cannabis use). The effect of maternal smoking 
on substance use is partially mediated by DNAm at birth. The sample in this study was underpowered to test for 
genetic effects, which may have moderated the a and/or b path.  
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Figure 3. A simplified, integrative model of the relationship between environmental risk 
exposure, DNAm and psychopathology 
 
The figure illustrates a simplified, integrative model of the relationship between environmental risks, DNAm 
and developmental psychopathology, and how this model relates to the mediation framework (right-hand side). 
Briefly, the top of the figure shows environmental effects on DNAm, how these may interact with - and be 
confounded by - genetic factors, and how they may be moderated by exposure characteristics. The dotted arrow 
on the left-hand side also demonstrates how environmental exposures may influence DNAm across multiple 
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generations, beginning with (empirically-supported) direct effects to hypothesised (but not empirically verified) 
indirect intergenerational effects. The middle of the figure depicts DNAm as the mediator, how it is embedded 
into the wider machinery of epigenetic regulation, and how it varies across multiple factors.  Together, these 
epigenetic changes are shown to influence gene activity and function, which in turn contribute to the 
programming of wider, interconnected biological systems (e.g. immune, neural and stress function). The bottom 
of the figure shows how this biological cascade modulates adaptation to the environment and disease 
susceptibility over the lifespan, shifting developmental trajectories (typical to atypical) and contributing to the 
phenotypic manifestations reviewed in this article, including internalising and externalising difficulties in 
childhood and adolescence. Of note, the trajectories depicted are only examples from a wide range of possible 
trajectories, and are modelled around findings regarding the development of conduct problems (Barker & 
Maughan, 2009). Abbreviations:  E-E, environment-environment; G-E, gene-environment; CP, conduct 
problems. 
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Figure 4. Analysis flowchart and methodological recommendations for future research 
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